Harmony Biosciences Holdings, Inc. (HRMY)
38.26
-2.02
(-5.01%)
USD |
NASDAQ |
Oct 12, 16:00
38.26
0.00 (0.00%)
After-Hours: 18:10
Harmony Biosciences Holdings Price : 38.26 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 39.53 | 40.57 | 39.51 | 40.28 | 487164.0 |
| Oct 08, 2026 | 39.14 | 39.89 | 38.68 | 39.60 | 865033.0 |
| Oct 07, 2026 | 39.27 | 39.86 | 39.10 | 39.34 | 547001.0 |
| Oct 06, 2026 | 40.09 | 40.35 | 38.91 | 39.36 | 507277.0 |
| Oct 05, 2026 | 39.76 | 40.77 | 39.51 | 39.92 | 897920.0 |
| Oct 02, 2026 | 39.78 | 40.62 | 39.25 | 39.64 | 916733.0 |
| Oct 01, 2026 | 39.58 | 40.46 | 39.08 | 39.57 | 1.228M |
| Sep 30, 2026 | 39.30 | 39.56 | 38.72 | 39.26 | 667692.0 |
| Sep 29, 2026 | 39.87 | 40.52 | 39.15 | 39.29 | 786676.0 |
| Sep 28, 2026 | 41.29 | 41.54 | 39.54 | 40.01 | 874387.0 |
| Sep 25, 2026 | 41.37 | 41.60 | 40.89 | 41.26 | 557011.0 |
| Sep 24, 2026 | 40.63 | 41.79 | 40.00 | 41.16 | 906463.0 |
| Sep 23, 2026 | 41.61 | 42.08 | 39.72 | 40.48 | 1.081M |
| Sep 22, 2026 | 42.10 | 42.37 | 41.36 | 41.53 | 577958.0 |
| Sep 21, 2026 | 41.87 | 42.52 | 41.20 | 42.10 | 839024.0 |
| Sep 18, 2026 | 42.57 | 43.27 | 41.90 | 42.02 | 3.821M |
| Sep 17, 2026 | 42.59 | 43.01 | 42.10 | 42.74 | 641414.0 |
| Sep 16, 2026 | 42.28 | 43.05 | 42.06 | 42.21 | 1.599M |
| Sep 15, 2026 | 41.64 | 42.19 | 40.94 | 42.17 | 1.213M |
| Sep 14, 2026 | 41.93 | 42.25 | 41.48 | 41.54 | 1.044M |
| Sep 11, 2026 | 41.30 | 41.72 | 40.92 | 41.52 | 1.123M |
| Sep 10, 2026 | 41.26 | 41.72 | 40.93 | 41.10 | 736834.0 |
| Sep 09, 2026 | 42.01 | 42.40 | 41.23 | 41.62 | 1.133M |
| Sep 08, 2026 | 42.20 | 43.25 | 41.56 | 42.07 | 1.778M |
| Sep 04, 2026 | 41.50 | 42.34 | 41.36 | 42.25 | 662547.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 27.65 |
| Pfizer Inc. | 28.42 |
| Bristol Myers Squibb Co. | 57.58 |
| Repligen Corp. | 172.54 |
| Johnson & Johnson | 263.95 |
Price Related Metrics
| PE Ratio | 12.40 |
| PS Ratio | 2.341 |
| Price to Book Value | 2.225 |
| Price to Free Cash Flow | 6.695 |
| Earnings Yield | 8.07% |
| Market Cap | 2.224B |
| Operating PE Ratio | 9.743 |
| Normalized PE Ratio | 12.40 |